1. AMR Alliance Japan Resources

• AMR Alliance Japan Policy Recommendations
• About AMR Alliance Japan
• Brief: Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
• Brief: Constructing domestic AMR surveillance and crisis management systems
• Brief: Enabling the further and active use of AMR screening methods and rapid diagnostic technology
• Brief: Supporting education on AMR for the public and medical practitioners
• Brief: Establishing incentive models to encourage R&D for antimicrobials
• Brief: Stabilizing the supply of antimicrobials
• Brief: International collaborations to share case studies and lessons learned about AMR.
• AMR Alliance Japan Recommendations on the Domestic AMR Surveillance System
• Recommendations Toward the Next National Action Plan
• Recommendations on the Stable Supply of Antimicrobials and Crisis in the Antimicrobial Market
• Report on the Meeting to Establish AMR Alliance Japan

2. AMR Alliance Japan Member Resources

Shionogi & Co., Ltd.

• • SHIONOGI ANTIMICROBIAL RESISTANCE (AMR) POSITION PAPER
  • AMR Measures Support Page (Japanese page)
  • Pediatric Infectious Diseases Navigator (Japanese page)
  • INFECTIOUS DISEASES TODAY

The Japanese Society for Medical Mycology

• • GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN

Japanese Society of Pharmaceutical Health Care and Sciences

• • Protocol Based Pharmacotherapy Management (PBPM) based on physician-pharmacist collaboration protocol for outpatient HIV and MRSA treatment (Mie University Hospital; Japanese page)

Japanese Society of Chemotherapy

• • About “Recommendations on AMR Countermeasures ” (Japanese page)
  • JID/JSC Guidelines for the Treatment of Infectious Diseases ― Respiratory Infections ― (Japanese page)
  • Practical guidelines for the management and treatment of infections caused by MRSA, 2019 Edition
  • Recommendations on Stabilizing the Supply of Antimicrobials from Four Academic Societies – Providing Peace of Mind for People Using Life-Saving Drugs –
  • Recommendations on Antimicrobial Stewardship from 8 infectious disease-related academic societies : Promoting Antimicrobial Stewardship (AS) programs -Background and Goal of Recommendations- (Japanese page)
  • Guidelines on the Clinical Evaluation of Antibiotic Use (Japanese page)
  • GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN
  • Recommendations on the Development of New Antimicrobials from 8 Academic Societies: “Global Cooperative Measures for AMR” – Background and Goal of Recommendations (Japanese page)
  • Recommendations on the Development of New Antibiotics from 6 Academic Societies – The Current Status of AMR Bacteria and the Need for Antimicrobial Drug Development -Background and Goal of Recommendations – (Japanese page)

Japanese Society for Infection Prevention and Control

• • Recommendations on Stabilizing the Supply of Antimicrobials from Four Academic Societies – Providing Peace of Mind for People Using Life-Saving Drugs –
  • Recommendations on Antimicrobial Stewardship from 8 infectious disease-related academic societies: Promoting Antimicrobial Stewardship (AS) programs – Background and Goal of Recommendations- (Japanese page)
  • GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN
  • Recommendations on the Development of New Antibiotics from 8 Academic Societies: “Global Cooperative Measures for AMR” – Background and Goal of Recommendations (Japanese page)
  • Recommendations on the Development of New Antibiotics from 6 Academic Societies – The Current Status of AMR Bacteria and the Need for Antimicrobial Drug Development (Japanese page)
  • Educational Tools of The Japanese Society for Infection Prevention and Control Ver.3 (Japanese page)

The Japanese Association for Infectious Diseases

• • Practical guidelines for the management and treatment of infections caused by MRSA, 2019 Edition
  • Characteristics of NDM-1 and NDM-1 producers (Japanese page)
  • Information for the general public: FAQs on multidrug-resistant bacteria (Japanese page)
  • Recommendations on antimicrobial stewardship related to respiratory tract infections (Japanese page)
  • Recommendations on Stabilizing the Supply of Antimicrobials from Four Academic Societies – Providing Peace of Mind for People Using Life-Saving Drugs –
  • Recommendations on Antimicrobial Stewardship from 8 infectious disease-related academic societies : Promoting Antimicrobial Stewardship (AS) programs -Background and Goal of Recommendations- (Japanese page)
  • GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN
  • Recommendations on the Development of New Antibiotics from 8 Academic Societies: “Global Cooperative Measures for AMR” – Background and Goal of Recommendations (Japanese page)
  • Recommendations on the Development of New Antibiotics from 6 Academic Societies – The Current Status of AMR Bacteria and the Need for Antimicrobial Drug Development -Background and Goal of Recommendations – (Japanese page)

Japanese Society for Pediatric Infectious Diseases

• • Tokyo Pediatric Infectious Diseases Seminar: Notification of Seminar on AMR among Children (Japanese page)
  • The 2nd Seminar on AMR among Children (Japanese page)
  • Supplement to the Guidelines for Managing of Respiratory Infections in Children 2011 (February 19, 2013) “Diagnosis and Treatment of Mycoplasma Pneumonia in Children” (Japanese page)

Japan Pharmaceutical Manufacturers Association

AMR General/AMR Countermeasures Awareness

• • Antimicrobial resistance (AMR)
  • STOP AMR
  • Public awareness raising video on promoting antimicrobial resistance(AMR) measures “STOP AMR”

Research and Development Promotion

• • Proposal regarding Measures for Research and Development Promotion of Drugs, etc. against Drug Resistance (AMR)
  • Proposal from the pharmaceutical industry about the introduction of pull-type incentives for promoting research and development of AMR drugs

Recommendations to the G7/G20

• • Requests for the Health Agendas at the G7 Ise-Shima Summit
  • Recommendations of the JPMA on the G7 Health Ministers’ Meeting (Outline)
  • Recommendations from the pharmaceutical industry for the G20 Osaka Summit Health Agenda
  • Recommendations from Pharmaceutical Industry for G20 Health Ministers Meeting
  • Joint IFPMA-JPMA-PhRMA Letter for G20 Japan-Saudi transition

Nippon Becton, Dickinson and Company, Ltd.

• • Public-Private Sector Collaboration to Address Antimicrobial Resistance
  • What You Can Do to Prevent Infections (Japanese page)
  • BD Solutions for AMR (Japanese page)
  • Infectious Disease Control Magazine “Ignazzo” (Japanese page)
  • The role of antimicrobial susceptibility testing in fighting AMR (Medical Tribune Special Interview; Japanese page)
  • How can advancements in the speed of antimicrobial susceptibility testing contribute to the National Action Plan on AMR (Medical Tribune Special Interview; Japanese page)
  • Antimicrobial Resistance Fighter Coalition

The Pharmaceutical Society of Japan

• • NDM -1 producing multidrug-resistant bacteria (Environmental and Health Subcommittee – Environmental and Health Topics) (Japanese page)
  • Fact Sheet: The Current Status of AMR Bacteria and the Need for Antimicrobial Drug Development (Japanese page)
  • Let’s review how to use antibiotics! (Japanese page)
  • Second Proposal by the Drug Discovery Promotion Review Committee and the Committee for the Promotion of Proper Use of Antimicrobials – Global Cooperative Measures for AMR (Japanese page)
  • Recommendations on the Development of New Antibiotics from 6 Academic Societies – The Current Status of AMR Bacteria and the Need for Antimicrobial Drug Development (Japanese page)
  • “Antibiogram” – Glossary of Pharmaceutical Sciences (Japanese page)
  • Recommendations on Antimicrobial Stewardship from 8 infectious disease-related academic societies : Promoting Antimicrobial Stewardship (AS) programs (Japanese page)
  • GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN

The Japanese Society for Clinical Microbiology

• • Recommendations on Antimicrobial Stewardship from 8 infectious disease-related academic societies : Promoting Antimicrobial Stewardship (AS) programs -Background and Goal of Recommendations- (Japanese page)
  • GUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN
  • Recommendations on the Development of New Antibiotics from 8 Academic Societies: “Global Cooperative Measures for AMR” – Background and Goal of Recommendations (Japanese page)
  • Recommendations on the Development of New Antibiotics from 6 Academic Societies – The Current Status of AMR Bacteria and the Need for Antimicrobial Drug Development -Background and Goal of Recommendations – (Japanese page)
  • The role of Microbiology laboratory in AMR action plan
  • National Action Plan on Antimicrobial Resistance (AMR) (Japanese page)
  • Regional cooperation in infection control measures and construction of a regional drug-resistant bacteria surveillance system (Japanese page)
  • Recommendations on Stabilizing the Supply of Antimicrobials from Four Academic Societies – Providing Peace of Mind for People Using Life-Saving Drugs –
  • Guidelines on Testing for Multidrug-Resistant Bacteria (Japanese page)
  • Emergence and evolution of microbial drug-resistance
  • A survey of trends in drug-resistant gram-negative bacilli in the Hokuriku District of Japan

bioMérieux Japan

• • bioMérieux Japan AMR Position Paper (Japanese Page)
  • AMR Public Awareness Content “Let’s change the future where antibiotics do not work” (Japanese Page)
  • ILLUSTRATED ENCYCLOPEDIA OF VIRUSES AND BACTERIA FOR RESPIRATORY INFECTIONS(Japanese Page)

Three Academic Societies Joint Antimicrobial Susceptibility Surveillance Program Database

• • Three Academic Societies Joint Antimicrobial Susceptibility Surveillance Program Database (Japanese page; Covers respiratory infections; dental and oral surgical infections; ear, nose, and throat infections; surgical site infections; pediatric infectious diseases; urinary tract infections; and dermatological infections)

3. External Resources on AMR

Year	Title	Author	Country/Region	Theme
2020	JANIS About Page	JANIS	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2018	JANIS Open Report	JANIS	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2018	Automated detection of outbreaks of antimicrobial-resistant bacteria in Japan	Journal of Hospital Infection	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2016	National Action Plan on Antibacterial Resistance (AMR) 2016-2020	The Government of Japan	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities/2. Constructing domestic AMR surveillance and crisis management systems/7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2017	Nippon AMR One Health Report 2017	The AMR One Health Surveillance Committee	Japan	2. Constructing domestic AMR surveillance and crisis management systems/7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019	Three Academic Societies Joint Antimicrobial Susceptibility Surveillance Program	Three Academic Societies Joint Antimicrobial Susceptibility Surveillance Program	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2019	Japan Antimicrobial Consumption Surveillance System (JACS)	JACS	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2020	Japan Surveilliance for Infection Prevention and Healthcare Epidemiology (J-SIPHE)	Japan Surveilliance for Infection Prevention and Healthcare Epidemiology (J-SIPHE)	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2018	Global Antimicrobial Resistance Surveillance (GLASS) Report 2016-2017	World Health Organization	Global	2. Constructing domestic AMR surveillance and crisis management systems/7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020	European Antimicrobial Resistance Surveillance Network (EARS-Net)	European Center for Disease Prevention and Control	Europe	2. Constructing domestic AMR surveillance and crisis management systems
2020	Latin American Network for Antimicrobial Resistance Surveillance - ReLAVRA	Pan American Health Organization	Latin America	2. Constructing domestic AMR surveillance and crisis management systems
2019	Central Asian and European Surveillance of Antimicrobial Resistance. Annual report 2019	World Health Organization Regional Office for Europe	Central Asia and Eastern Europe	2. Constructing domestic AMR surveillance and crisis management systems
2019	The National Antimicrobial Resistance Monitoring System (NARMS)	Center for Disease Control and Prevention	United States	2. Constructing domestic AMR surveillance and crisis management systems
2017	AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS)	Wellcome Open Reserch	Low-middle income countries	2. Constructing domestic AMR surveillance and crisis management systems
2020	ICT & AST	Center Hospital of the National Center for Global Health and Medicine	Japan	2. Constructing domestic AMR surveillance and crisis management systems/3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology/4. Supporting education on AMR for the public and medical practitioners
2015	Rapid Diagnostic: Stopping Unnecessary Use of Antibiotics	Wellcome Trust	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020	the Joint Programming Initiative on Antimicrobial Resistance	Joint Programming Initiative on Antimicrobial Resistance	Europe	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020	Joint Programming Initiative on Antimicrobial Resistance: Japan	Joint Programming Initiative on Antimicrobial Resistance	Japan	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020	AMR Dx Global	Joint Programming Initiative on Antimicrobial Resistance	Europe	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	AMR Diagnostic Challenge	National Institutes of Health	United States	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories	BMC Health Services Research	Japan	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2015	Infection Prevention, Control and Surveillance: Limiting the Development and Spread of Drug Resistance	Wellcome Trust	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017	White Paper on Rapid Diagnostic Technlogies to Tackle AMR	Health First Europe	Europe	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	Innovation in AMR: patents trends for novel diagnostics	Longitude Prize	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016	Diagnostic stewardship：A guide to implementation in antimicrobial resistance surveillance sites	World Health Organization	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System	World Health Organization	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016	Emerging Technlogies for Clinical Microbiology Laboratory: Rapid Antimicrobial Susceptibility Testing Update	Kanto Chemical Co., Inc.	Japan	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017	Advances in Rapid Identification and Sucseptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs	Infectious Disease Report	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	Advances in Diagnostic Testing that Impact Infection Prevention and Antimicrobial Stewardship Programs	Current Infectious Disease Reports	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	WHO Competency Framework for Health Workers’ Education and Training on Antimicrobial Resistance	World Health Organization	Global	4. Supporting education on AMR for the public and medical practitioners
2020	AMR Clinical Reference Center	National Center for Global Health and Medicine	Japan	4. Supporting education on AMR for the public and medical practitioners
2020	e-Bug	UK Health Protection Agency (HPA)	United Kingdom	4. Supporting education on AMR for the public and medical practitioners
2020	AMR Clinical Reference Center Educational Resources, AMR Learning	National Center for Global Health and Medicine	Japan	4. Supporting education on AMR for the public and medical practitioners
2015	Securing New Drugs for Future Generations: The Pipeline of Antibiotics	Wellcome Trust	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2013	Japan and Partners Team Up to Tackle Neglected Diseases	Scientific American	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship—A Tale of Two Countries	Frontiers in Public Health	Global	6. Stabilizing the supply of antimicrobials
2016	Tackling Drug-Resistant Infections Globally: Final Report and Recommendations	Wellcome Trust	Global	6. Stabilizing the supply of antimicrobials
2020	Global Research Collaboration for Infectious Disease Preparedness	Mérieux Foundation	Japan	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020	GenEpid-J：Database of Pathogen Genomics and Epidemiology	National Institute of Infectious Diseases	Japan	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2014	Enhancing US-Japan Cooperation to Combat Antimicrobial Resistance	Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science	Japan	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015	Global action plan on antimicrobial resistance	World Health Organization	Global	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities 4. Supporting education on AMR for the public and medical practitioners 7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020	Global AMR R&D Hub	Global AMR R&D Hub	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Access to Medicine Index 2018	Access to Medicine Foundation	Global	6. Stabilizing the supply of antimicrobials
2017	What is antimicrobial stewardship?	Dyar, O. J., B. Huttner, J. Schouten, and C. Pulcini.	Global	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2019	Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit	World Health Organization	Low-middle income countries	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2016	Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009–2013)	Muraki, Yuichi, Tetsuya Yagi, Yasuhiro Tsuji, Nobuhiro Nishimura, Masaki Tanabe, Takashi Niwa, Tamayo Watanabe et al.	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018	Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016	Tsutsui, Atsuko, Koji Yahara, and Keigo Shibayama	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020	Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012–2015	Hashimoto, Hideki, Makoto Saito, Jumpei Sato, Kazuo Goda, Naohiro Mitsutake, Masaru Kitsuregawa, Ryozo Nagai, and Shuji Hatakeyama	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018	vol.9 The current state of drug resistance as seen in data. 2018-Let's know AMR, let's think about your medicine-	AMR Clinical Reference Center	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2017	Manual of Antimicrobial Stewardship (1st Edition)	Ministry of Health, Labour, and Welfare	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020	A nationwide questionnaire survey of clinic doctors on antimicrobial stewardship in Japan	Gu, Yoshiaki, Yumiko Fujitomo, Hiroshi Soeda, Chikara Nakahama, Naoki Hasegawa, Shigefumi Maesaki, Masayuki Maeda, Tetsuya Matsumoto, Isao Miyairi, and Norio Ohmagari	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities 4. Supporting education on AMR for the public and medical practitioners
2019	Manual of Antimicrobial Stewardship (2nd Edition)	Ministry of Health, Labour, and Welfare	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018	Additional reimbursement for antimicrobial stewardship – 100 points	Ministry of Health, Labour, and Welfare	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2019	The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy	Maeda, Masayuki, Yuichi Muraki, Tadashi Kosaka, Takehiro Yamada, Yosuke Aoki, Mitsuo Kaku, Tatsuya Kawaguchi et al.	Japan	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018	Global increase and geographic convergence in antibiotic consumption between 2000 and 2015	Klein, Eili Y., Thomas P. Van Boeckel, Elena M. Martinez, Suraj Pant, Sumanth Gandra, Simon A. Levin, Herman Goossens, and Ramanan Laxminarayan	Global	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities 3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	WHO Report on Surveillance of Antibiotic Consumption	World Health Organization	Global	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2015	Global trends in antimicrobial use in food animals	Van Boeckel, Thomas P., Charles Brower, Marius Gilbert, Bryan T. Grenfell, Simon A. Levin, Timothy P. Robinson, Aude Teillant, and Ramanan Laxminarayan	Global	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2008	Antimicrobial drug use and resistance in Europe	Van De Sande-Bruinsma, Nienke, Hajo Grundmann, Didier Verloo, Edine Tiemersma, Jos Monen, Herman Goossens, Matus Ferech, and European Antimicrobial Resistance Surveillance System	Europe	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2017	Global Framework for Development & Stewardship to Combat Antimicrobial Resistance	World Health Organization	Global	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2019	Antibiotic Use in the United States, 2018 Update: Progress and Opportunities	Center for Disease Control and Prevention	United States	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020	TARGET Antibiotics Toolkit	Royal College of General Practitioners	United Kingdom	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020	The South African Antibiotic Stewardship Progrmme (SAASP)	Federation of Infectious Diseases Societies of Southern Africa	South Africa	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2013	The Viet Nam Resistance Project Tackles Looming Antibiotic Crisis	Asian Scientist	Vietnam	1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018	Surveillance	Japan International Cooperation Agency	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2018	Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories	Tsutsui, Atsuko, and Satowa Suzuki	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2018	AMR Indicators and their relevance to the global indicator framework for the SDGs and targets for the 2030 Agenda for Sustainable Development	World Health Organization	Global	2. Constructing domestic AMR surveillance and crisis management systems
2013	Infectious Disease Control Law	Ministry of Health, Labour, and Welfare	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2020	JANIS: List of participating institutions	Ministry of Health, Labour, and Welfare	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2019	Budget request for fiscal year 2020	Ministry of Health, Labour, and Welfare	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2019	Guidance for responding to antimicrobial resistant bacteria in small and medium sized hospitals	AMR Clinical Reference Center	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2019	Access to nationwide antimicrobial resistance (AMR) countermeasures by medical facilities: release of J-SIPHE platform	AMR Clinical Reference Center	Japan	2. Constructing domestic AMR surveillance and crisis management systems
2019	Global antimicrobial resistance surveillance system (GLASS) report 2017-2018	World Health Organization	Global	2. Constructing domestic AMR surveillance and crisis management systems 7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019	GLASS Enrolled countries – Feb 2020	World Health Organization	Global	2. Constructing domestic AMR surveillance and crisis management systems
2014	The bigger picture: the history of antibiotics and antimicrobial resistance displayed by scientometric data	Brandt, Christian, Oliwia Makarewicz, Thomas Fischer, Claudia Stein, Yvonne Pfeifer, Guido Werner, and Mathias W. Pletz	Global	2. Constructing domestic AMR surveillance and crisis management systems
2016	Antimicrobial resistance: A manual for developing national action plans	World Health Organization, Food and Agriculture Organization of the United Nations, World Organization for Animal Health	Global	2. Constructing domestic AMR surveillance and crisis management systems
2019	Library of national action plans	World Health Organization	Global	2. Constructing domestic AMR surveillance and crisis management systems
2015	U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (National Action Plan)	Center for Disease Control and Prevention	United States	2. Constructing domestic AMR surveillance and crisis management systems
2018	Global Infection Prevention and Control Network Meeting Report	World Health Organization	Global	2. Constructing domestic AMR surveillance and crisis management systems
2018	G20 experts stage a fake superbug pandemic to test how the world would react to a deadly outbreak of an antibiotic-resistant disease	Blanchard, Sam	Global	2. Constructing domestic AMR surveillance and crisis management systems
2016	Declaration by Pharmaceutical, Biotechnology and Diagnostic Industries on Combating Antimicrobial Resistance	AMR Industry Alliance	Global	2. Constructing domestic AMR surveillance and crisis management systems 7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016	Infection prevention, control and surveillance: Limiting the development and spread of drug resistance - review on antimicrobial resistance	O’Neill, Jim	Global	2. Constructing domestic AMR surveillance and crisis management systems
2019	Antibiotic prescribing without documented indication in ambulatory care clinics: national cross sectional study	Ray, Michael J., Gregory B. Tallman, David T. Bearden, Miriam R. Elman, and Jessina C. McGregor	United States	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017	The White Paper on rapid diagnostic technologies to tackle AMR	Health First Europe	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016	Microbiological testing method useful for measures against AMR ~Screening and Identification of AMR~	Nakamura, Tatsuya	Japan	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	Innovation in AMR: patent trends for novel diagnostics longitude prize	Longitude Prize	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	G20 Osaka leaders’ declaration	G20	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology 7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019	Okayama Declaration of the G20 Health Ministers	G20	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology 6. Stabilizing the supply of antimicrobials
2017	Emerging and re-emerging infectious disease control project	Japan Agency for Medical Research and Development (AMED)	Japan	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	FY2019 (Reiwa 1) Institutions / Topic List- Research Project for Practical Research of Infectious Diseases (Project for Promoting Development of Innovative Drugs for Emerging and Re-emerging Infectious Diseases)	Japan Agency for Medical Research and Development (AMED)	Japan	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017	Microbial testing/rapid testing/cytology testing	Becton Dickinson and Company Japan	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	Potential for reducing inappropriate antibiotic prescribing in English primary care	Smieszek, Timo, Koen B. Pouwels, F. Christiaan K. Dolk, David RM Smith, Susan Hopkins, Mike Sharland, Alastair D. Hay, Michael V. Moore, and Julie V. Robotham	United Kingdom	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018	The $28+ Billion Worldwide Market for Rapid Diagnostic Kits (2018-2023)	GlobalNewsWire	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package.	Hays, John P., Konstantinos Mitsakakis, Saturnino Luz, Alex van Belkum, Karsten Becker, Ann van den Bruel, Stephan Harbarth et al.	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020	Longitude Prize	Longitude Prize	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016	Ensuring innovation in diagnostics for bacterial infection: Implications for policy	World Health Organization	Global	3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019	How to improve antibiotic awareness campaigns: findings of a WHO global survey	Huttner, Benedikt, Mirko Saam, Lorenzo Moja, Karen Mah, Marc Sprenger, Stephan Harbarth, and Nicola Magrini	Global	4. Supporting education on AMR for the public and medical practitioners
2010	The English antibiotic awareness campaigns: did they change the public's knowledge of and attitudes to antibiotic use?	McNulty, Cliodna AM, Tom Nichols, Paul J. Boyle, Mark Woodhead, and Peter Davey	United Kingdom	4. Supporting education on AMR for the public and medical practitioners
2019	2019 Survey on Healthcare in Japan	Health and Global Policy Institute	Japan	4. Supporting education on AMR for the public and medical practitioners
2018	More than 80% of Americans are concerned about health threat posed by antibiotic resistance	Research!America	United States	4. Supporting education on AMR for the public and medical practitioners
2017	Public Awareness Raising Activities on AMR	Hasegawa, Manabu	Japan	4. Supporting education on AMR for the public and medical practitioners
2019	Public Awareness and Educational Activities to Improve Knowledge and Understanding of Antimicrobial Resistance (AMR) in Japan	Akie Araim, Yoshinori Takahashi, Akiko Nakamura, Masaki Tanabe	Japan	4. Supporting education on AMR for the public and medical practitioners
2015	Antibiotic resistance: Multi-country public awareness survey”	World Health Organization	Global	4. Supporting education on AMR for the public and medical practitioners
2013	Public knowledge, attitudes, and experience regarding the use of antibiotics in Italy	Napolitano, Francesco, Maria Teresa Izzo, Gabriella Di Giuseppe, and Italo F. Angelillo	Italy	4. Supporting education on AMR for the public and medical practitioners
2019	Public understanding and use of antibiotics in England: findings from a household survey in 2017	McNulty, Cliodna AM, Simon M. Collin, Emily Cooper, Donna M. Lecky, and Chris C. Butler	England	4. Supporting education on AMR for the public and medical practitioners
2010	A survey of public knowledge and awareness related to antibiotic use and resistance in Sweden	André, Malin, Åsa Vernby, Johanna Berg, and Cecilia Stålsby Lundborg	Sweden	4. Supporting education on AMR for the public and medical practitioners
2013	Medical students’ perceptions and knowledge about antimicrobial stewardship: how are we educating our future prescribers?	Abbo, Lilian M., Sara E. Cosgrove, Paul S. Pottinger, Margaret Pereyra, Ronda Sinkowitz-Cochran, Arjun Srinivasan, David J. Webb, and Thomas M. Hooton	England	4. Supporting education on AMR for the public and medical practitioners
2017	Canadian physicians’ knowledge and counseling practices related to antibiotic use and antimicrobial resistance: Two-cycle national survey	Smith, Courtney R., Lisa Pogany, Simon Foley, Jun Wu, Karen Timmerman, Margaret Gale-Rowe, and Alain Demers	Canada	4. Supporting education on AMR for the public and medical practitioners
2019	Knowledge and Attitude of General Pakistani Population Towards Antibiotic Resistance	Akhund, Ramsha, Fatima Jamshed, Hassam A. Jaffry, Hamza Hanif, and Sundus Fareed	Pakistan	4. Supporting education on AMR for the public and medical practitioners
2018	The consequences of AMR education and awareness raising: outputs, outcomes, and behavioural impacts of an antibiotic-related educational activity in Lao PDR.	Haenssgen, Marco J., Thipphaphone Xayavong, Nutcha Charoenboon, Penporn Warapikuptanun, and Yuzana Khine Zaw	Laos	4. Supporting education on AMR for the public and medical practitioners
2019	World Antibiotic Awareness Week	World Health Organization	Global	4. Supporting education on AMR for the public and medical practitioners
2011	Overview of e-Bug: an antibiotic and hygiene educational resource for schools	McNulty, Cliodna AM, Donna M. Lecky, David Farrell, Patty Kostkova, Niels Adriaenssens, Tereza Koprivová Herotová, Jette Holt et al	Europe	4. Supporting education on AMR for the public and medical practitioners
2012	Antibiotic prescribing in primary care, adherence to guidelines and unnecessary prescribing-an Irish perspective	Murphy, Marion, Colin P. Bradley, and Stephen Byrne	Ireland	4. Supporting education on AMR for the public and medical practitioners
2020	ReACT - About us	ReACT	Global	4. Supporting education on AMR for the public and medical practitioners 7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020	Read Antimicrobial Resistance Fighter Stories	Antimicrobial Resistance Fighter Coalition	Global	4. Supporting education on AMR for the public and medical practitioners
2019	Superheroes Against Superbugs Pilot Report	WellcomeTrust/DBT Indian Alliance, World Comics India, Centre for Cellular and Molecular Biology	India	4. Supporting education on AMR for the public and medical practitioners
2011	Challenges of antibacterial discovery	Silver, Lynn L	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2019	(Inter) nationalising the antibiotic research and development pipeline	Singer, Andrew C., Claas Kirchhelle, and Adam P. Roberts	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050	Hu, Charlotte	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Achaogen bankruptcy highlights antibacterial development woes	Mullard, Asher	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	The need for AMR pull incentives	International Federation of Pharmaceutical Manufactures & Associations	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2017	Antimicrobial Reistance (AMR) Symposium: AMED The Forefront of R&D from basics to drug discovery - AMR Research, Current State of the World	Tateda, Kazuhiro	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Although the market is expanding 1.9 times, it is the beginning of the negative growth era – reflecting on the pharmaceufcal market data during the Heisei era	Maeda, Yuki	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2017	[Fuji Economic Survey] Infectious Diseases Market, 30% decrease to 555.2 billion yen in 2024	Yakuji Nippo, Ltd.	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2013	Strategy and direction to overcome stagnation of antimicrobial development	Tateda, Kazuhiro	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2018	CiCLE: Cyclic Innovation for Clinical Empowerment	Japan Agency for Medical Research and Development (AMED)	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Research Project to Promote the Development of Innovative Drugs for Emerging and Re-Emerging Infectious Diseases	Japan Agency for Medical Research and Development (AMED)	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2017	Scheme to expedite unapproved drugs for antimicrobial resistant diseases to incentivize development	Ministry of Health, Labour, and Welfare	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2018	GARDP, Eisai and Takeda announce partnership in the search for new antibiotics	Takeda Pharmaceuticals Co., Ltd.	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Japan Archives – AMR Industry Alliance	AMR Industry Alliance	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2019	FY2019 (Reiwa 1) Institutions / Topic List- Research Project for Practical Research of Infectious Diseases	Japan Agency for Medical Research and Development (AMED)	Japan	5. Establishing incentive models to encourage R&D for antimicrobials
2017	Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation	Towse, Adrian, Christopher K. Hoyle, Jonathan Goodall, Mark Hirsch, Jorge Mestre-Ferrandiz, and John H. Rex	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Antibiotics Aren’t Profitable Enough for Big Pharma to Make More	Langreth, Robert	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Global Health Observatory on Health R&D: Antibacterial products in clinical development for priority pathogens	World Health Organization	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Medicines in Development for Cancer 2018 Report	Pharmaceutical Research and Manufactures of America	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2019	The global preclinical antibacterial pipeline	Theuretzbacher, Ursula, Kevin Outterson, Aleks Engel, and Anders Karlén	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2020	Research and Development	Global Antibiotic Research and Development Partnership	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	GARDP: a not-for-profit research and development organization to address antimicrobial resistance	Drugs for Neglected Diseases initiative	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2020	Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator - Overview	Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2016	Economic incentives for antibacterial drug development: literature review and considerations from the Transatlantic Task Force on Antimicrobial Resistance	Sciarretta, Kimberly, John-Arne Røttingen, Aleksandra Opalska, Arjon J. Van Hengel, and Joseph Larsen	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2020	ND4BB: New Drugs for Bad Bugs	Innovative Medicines Initiative	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Boosting the fight against drug­ resistant bacteria in hospitals	Innovative Medicines Initiative	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2020	ENABLE: European Gram­Negative Antibacterial Engine	Innovative Medicines Initiative	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2017	Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.	Chan, Pan F., Thomas Germe, Benjamin D. Bax, Jianzhong Huang, Reema K. Thalji, Eric Bacqué, Anna Checchia et al.	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Joint Programming Initiative on Antimicrobial Resistance - Supported projects.	Joint Programming Initiative on Antimicrobial Resistance	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2020	REPAIR Impact Fund - About	Novo Nordsik Foundation	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2019	Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan	United Kingdom Government	United Kingdom	5. Establishing incentive models to encourage R&D for antimicrobials
2018	Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come	AMR Industry Alliance	Global	5. Establishing incentive models to encourage R&D for antimicrobials
2017	International Strategy	Medicines and Healthcare Products Regulatory Agency	Global	6. Stabilizing the supply of antimicrobials
2013	Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists	Gundlapalli, Adi V., Susan E. Beekmann, Donald R. Graham, Philip M. Polgreen, and Infectious Diseases Society of America's Emerging Infections Network	United States	6. Stabilizing the supply of antimicrobials
2020	Critical national shortage of cefazolin in Japan: management strategies	Honda, Hitoshi, Shutaro Murakami, Yasuharu Tokuda, Yasuaki Tagashira, and Akane Takamatsu	Japan	6. Stabilizing the supply of antimicrobials
2019	Suspension of cefazolin, surgeries affected, hospitals in panic	Asahi Shimbun	Japan	6. Stabilizing the supply of antimicrobials
2019	Recommendations by four academic societies for the stable supply of antimicrobials	Japan Society for Infection Prevention and Control, Japan Society of Chemotherapy, the Japan Association of Infectious Diseases, and Japan Society of Clinical Microbiology	Japan	6. Stabilizing the supply of antimicrobials
2019	IQVIA Heisei era’s drug market: Antibacterial drugs in the first half, lifestyle-related drugs in the second half, antitumor drugs in the second half dominate	Mix	Japan	6. Stabilizing the supply of antimicrobials
2019	Nichi-Iko invests 1.5 billion yen in stable supply of cefazolin	Nikkei Medical	Japan	6. Stabilizing the supply of antimicrobials
2015	Antibacterial drug shortages from 2001 to 2013: implications for clinical practice.	Quadri, Farha, Maryann Mazer-Amirshahi, Erin R. Fox, Kristy L. Hawley, Jesse M. Pines, Mark S. Zocchi, and Larissa May	Global	6. Stabilizing the supply of antimicrobials
2018	Shortages, stockouts and scarcity	Cogan, Deirdre, Karrar Karrar, and Jayasree K. Iyer	Global	6. Stabilizing the supply of antimicrobials
2019	Meeting report: antibiotic shortages: magnitude, causes and possible solutions	World Health Organization	Global	6. Stabilizing the supply of antimicrobials
2019	Drug Shortages: Root Causes and Potential Solution	Food and Drug Administration	United States	6. Stabilizing the supply of antimicrobials
2011	Prescription drug shortages: examining a public health concern and potential solutions.	United States Committee on Health, Education, Labor, and Pensions	Global	6. Stabilizing the supply of antimicrobials
2018	Fragile Antibiotic Supply Chain Causes Shortages And Is A National Security Threat	Stone, Judy	Global	6. Stabilizing the supply of antimicrobials
2019	Access Barriers to Antibiotics	Center for Disease Dynamics, Economics & Policy	Global	6. Stabilizing the supply of antimicrobials
2014	Drive-AB - About	Drive-AB	Global	6. Stabilizing the supply of antimicrobials
2019	Shionogi announces out-licensing agreement with AMR Centre on COT-143, a humanized monoclonal antibody targeting the PcrV protein of Pseudomonas aeruginosa	Shionogi & Co., Ltd.	Global	6. Stabilizing the supply of antimicrobials
2014	Annual report of the network for monitoring/surveillance of antibiotic resistance and health care associated infections – 2014	Pan American Health Organization	Americas	2. Constructing domestic AMR surveillance and crisis management systems
2017	One Health	World Health Organization	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015	The article by Prime Minister Shinzo Abe on the Lancet. Japan's vision for a peaceful and healthier world	Ministry of Foreign Affairs	Japan	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015	Japan’s vision for a peaceful and healthier world	Ministry of Foreign Affairs	Japan	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015	Global trends in antimicrobial use in food animals	Van Boeckel, Thomas P., Charles Brower, Marius Gilbert, Bryan T. Grenfell, Simon A. Levin, Timothy P. Robinson, Aude Teillant, and Ramanan Laxminarayan	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019	Antimicrobial Resistance in the Asia Pacific region: a meeting report	Yam, Esabelle Lo Yan, Li Yang Hsu, Eric Peng-Huat Yap, Tsin Wen Yeo, Vernon Lee, Joergen Schlundt, May O. Lwin et al	Asia-Pacific	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019	Chair Summary Tokyo AMR One Health Conference	Ministry of Health, Labour, and Welfare	Japan	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019	The 6th Nikkei Asia Africa Conference on Communicable Diseases 2019 – Big Step towards Borderless Initiative through Public-Private Partnership	The Nihon Keizai Shimbun	Asia/Africa	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016	UN Interagency Coordination Group (IACG) on Antimicrobial Resistance	World Health Organization	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2018	A new alliance joins the fight against antimicrobial resistance	Burki, Talha Khan	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016	The FAO action plan on antimicrobial resistance 2016–2020	Food and Agriculture Organization of the United Nations (FAO)	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016	The OIE strategy on antimicrobial resistance and the prudent use of antimicrobials	World Organization for Animal Health	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016	Draft political declaration of the high-level meeting of the General Assembly on antimicrobial resistance	United Nations	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2018	Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)	Center for Disease Control and Prevention	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2017	AMR Industry Alliance - Why the AMR Industry Alliance?	AMR Industry Alliance	Global	7. International collaborations to share case studies and lessons learned on AMR domestically and abroad